News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Goldberg Mark Alan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 9,167 shares
@ $1.5, valued at
$13.8k
|
|
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 894 shares
@ $18.87, valued at
$16.9k
|
|
| 06/16/2023 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 13,090 restricted stock units
@ $0
Granted 19,597 options to buy
@ $0 |
|
| 01/04/2023 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 3,402 restricted stock units
@ $0 |
|
| 10/04/2022 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 3,530 restricted stock units
@ $0 |
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 2,600 shares
@ $0
Granted 5,300 options to buy
@ $50.64, valued at
$268.4k
|
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 3,151 restricted stock units
@ $0 |
|
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 1,819 restricted stock units
@ $0 |
|
| 10/01/2021 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 2,380 restricted stock units
@ $0 |
|
| 07/02/2021 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 2,048 restricted stock units
@ $0 |
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 2,250 shares
@ $0
Granted 4,500 options to buy
@ $87.13, valued at
$392.1k
|
|
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 3,452 shares
@ $4.02, valued at
$13.9k
|
|
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 5,455 shares
@ $125, valued at
$681.9k
Exercised 5,455 options to buy
@ $28.15, valued at
$153.6k
|
|
| 12/22/2020 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 5,454 shares
@ $120, valued at
$654.5k
Exercised 5,454 options to buy
@ $28.15, valued at
$153.5k
|
|
| 12/15/2020 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 5,455 shares
@ $115, valued at
$627.3k
Exercised 5,455 options to buy
@ $28.15, valued at
$153.6k
|
|
| 12/03/2020 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 5,454 shares
@ $110, valued at
$599.9k
Exercised 5,454 options to buy
@ $28.15, valued at
$153.5k
|
|
| 10/21/2020 |
4
| Goldberg Mark Alan (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 5,455 shares
@ $105, valued at
$572.8k
Exercised 5,455 options to buy
@ $19.53, valued at
$106.5k
|
|
| 10/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|